24756-1-AP

antibody from Proteintech Group

Targeting: VHL VHL1

Western blot (Data presented on provider website)

ELISA (Data presented on provider website)

Immunocytochemistry (Data presented on provider website)

Antibody Data

Product number

24756-1-AP

Provider

Proteintech Group

Product name

VHL antibody

Antibody type

Polyclonal

Description

VHL antibody (Cat. #24756-1-AP) is a rabbit polyclonal antibody that shows reactivity with human and has been validated for the following applications: IF, WB,ELISA.

Reactivity

Human

Host

Rabbit

Conjugate

Unconjugated

Isotype

IgG

Vial size

20ul, 150ul

References

Submitted references

Highly potent and selective degrader targeting ERα to improve the treatment outcomes of breast cancer.

Bao X, Yin X, Xu J, Zhu Z, Lu W, Cai Y, Dai R, Zheng Z, Xu W, Mei S, Xu S, Li J, Li N, Zhu H, Wang J, Liu J
European journal of medicinal chemistry 2026 Jan 5;301:118199

---

C-Arg9-APCR3-VHL promotes β-catenin degradation via the VHL-mediated ubiquitin-proteasome system in APC-mutant colorectal cancer.

Luo P, Shi W, Tian L, Li Y, Cheng X, Yang J, Li Y, Dong J
International journal of biological macromolecules 2025 Sep;322(Pt 1):146678

---

PROTAR Vaccine 2.0 generates influenza vaccines by degrading multiple viral proteins.

Zhang C, Hou J, Li Z, Shen Q, Bai H, Chen L, Shen J, Wang P, Su Y, Li J, Zhang Q, Liu C, Xi X, Qi F, Chen Y, Xie X, Ye AY, Liu X, Plebani R, Church G, Si L
Nature chemical biology 2025 Sep;21(9):1330-1340

---

Cytoplasmic TRIM24 promotes colorectal cancer cell proliferation by activating Wnt/β-catenin signaling.

Wang Y, Yao Y, Liu Z, Long S, Yi F, Fang Q, Wu D, Zhu Q, Zai H, Xiao S, Wan F, Fu K
Nature communications 2025 Sep 29;16(1):8598

---

RPL6 Interacts with HMGCS1 to Stabilize HIF-1α by Promoting Cholesterol Production in Hepatocellular Carcinoma.

Yang M, Cheng S, Gu H, Zhong S, Zhang D, He X, Chen W, Deng H, Ren J, Chen P, Tan M, Zhang H, Li F, Zhang Z, Hu Y, Chen J
Advanced science (Weinheim, Baden-Wurttemberg, Germany) 2025 Oct;12(38):e01373

---

VHL ameliorates arecoline-induced oral submucosal fibrosis by promoting HDAC6 ubiquitination and blocking NF-κB pathway.

Sun H, Yang C, Yin X, Chen S, Huang Y, Kuang H, Luo W
Scientific reports 2025 Mar 4;15(1):7563

---

AMPK-regulated glycerol excretion maintains metabolic crosstalk between reductive and energetic stress.

Zhai X, Yang R, Chu Q, Guo Z, Hou P, Li X, Bai C, Lu Z, Qiao L, Fu Y, Niu J, Li B
Nature cell biology 2025 Jan;27(1):141-153

---

Targeted Degradation of HCV Polymerase by GalNAc-Conjugated ApTACs for Pan-Genotypic Antiviral Therapy with High Resistance Barriers.

Pan W, Wu S, Zhou H, Xia Y, Li Q, Ge R, Wu J, Han H, Chen S, Li Y, Li J, Chen M, Liu M, Zhou J, Xie S
Journal of medicinal chemistry 2025 Jan 23;68(2):1473-1482

---

VH032 suppresses glioma proliferation by inhibiting the VHL/HIF-1α/VEGF pathway.

Zhang Y, Zhu XY, Gu JR, Wang P, Wen YJ, Hou SZ, Yang JY, Gu JH
Biochemistry and biophysics reports 2025 Dec;44:102254

---

Comprehensive analysis of angiogenesis and stemness-related genes in chemotherapy and immunotherapy of bladder cancer.

Yin ZX, Qiu Y, Xu C, Pei C
Biomolecules & biomedicine 2025 Apr 18;25(10):2209-2228

---

UBE2S promotes glycolysis in hepatocellular carcinoma by enhancing E3 enzyme-independent polyubiquitination of VHL.

Zhang R, Li C, Zhang S, Kong L, Liu Z, Guo Y, Sun Y, Zhang C, Yong Y, Lv J, Lu M, Liu M, Wu D, Zhang T, Yang H, Wei D, Chen Z, Bian H
Clinical and molecular hepatology 2024 Oct;30(4):771-792

---

CCT6A alleviates pulmonary fibrosis by inhibiting HIF-1α-mediated lactate production.

Yan P, Yang K, Xu M, Zhu M, Duan Y, Li W, Liu L, Liang C, Li Z, Pan X, Wang L, Yu G
Journal of molecular cell biology 2024 Oct 21;16(5)

---

Tumor-associated macrophages/C-X-C motif chemokine ligand 1 promotes breast cancer autophagy-mediated chemoresistance via IGF1R/STAT3/HMGB1 signaling.

Yang B, Li G, Wang S, Zheng Y, Zhang J, Pan B, Wang N, Wang Z
Cell death & disease 2024 Oct 11;15(10):743

---

Design of Murine Double Minute 2 Proteolysis Targeting Chimera Degraders with a Built-In Tumor-Targeting Ability.

Wang Z, Yue S, Chen X, Li J, Zhu P, Chen H, Qiu F, Xie D, Liang Y, Li D, Lu A, Liang C
Journal of medicinal chemistry 2024 Nov 14;67(21):18865-18882

---

TET3-overexpressing macrophages promote endometriosis.

Lv H, Liu B, Dai Y, Li F, Bellone S, Zhou Y, Mamillapalli R, Zhao D, Venkatachalapathy M, Hu Y, Carmichael GG, Li D, Taylor HS, Huang Y
The Journal of clinical investigation 2024 Nov 1;134(21)

---

MITF regulates the subcellular location of HIF1α through SUMOylation to promote the invasion and metastasis of daughter cells derived from polyploid giant cancer cells.

Zheng M, Tian S, Zhou X, Yan M, Zhou M, Yu Y, Zhang Y, Wang X, Li N, Ren L, Zhang S
Oncology reports 2024 May;51(5)

---

Identification of TAP1 as a T-cell related therapeutic target in gastric cancer by mediating oxalipliatin-related synergistic enhancement of immunotherapy.

Zhao Y, Liu Z, Deng K, Qu H, Zhang Q, Zhou P, Yang M, Yang X, Wang H, Li R, Xia J
International immunopharmacology 2024 May 10;132:111998

---

DNMT3A loss drives a HIF-1-dependent synthetic lethality to HDAC6 inhibition in non-small cell lung cancer.

Zhang J, Zhao Y, Liang R, Zhou X, Wang Z, Yang C, Gao L, Zheng Y, Shao H, Su Y, Cui W, Jia L, Yang J, Wu C, Wang L
Acta pharmaceutica Sinica. B 2024 Dec;14(12):5219-5234

---

FGD5 in basal cells induces CXCL14 secretion that initiates a feedback loop to promote murine mammary epithelial growth and differentiation.

Zhang T, Zhao C, Li Y, Wu J, Wang F, Yu J, Wang Z, Gao Y, Zhao L, Liu Y, Yan Y, Li X, Gao H, Hu Z, Cui B, Li K
Developmental cell 2024 Aug 19;59(16):2085-2100.e9

---

Hypoxia-induced downregulation of PGK1 crotonylation promotes tumorigenesis by coordinating glycolysis and the TCA cycle.

Guo Z, Zhang Y, Wang H, Liao L, Ma L, Zhao Y, Yang R, Li X, Niu J, Chu Q, Fu Y, Li B, Yang C
Nature communications 2024 Aug 12;15(1):6915

---

MDM2 promotes cancer cell survival through regulating the expression of HIF-1α and pVHL in retinoblastoma.

Zhang S, Xu H, Li W, Ji J, Jin Q, Chen L, Gan Q, Tao Q, Chai Y
Pathology oncology research : POR 2023;29:1610801

---

A mitochondrial EglN1-AMPKα axis drives breast cancer progression by enhancing metabolic adaptation to hypoxic stress.

Jiang W, Zhang M, Gao C, Yan C, Gao R, He Z, Wei X, Xiong J, Ruan Z, Yang Q, Li J, Li Q, Zhong Z, Zhang M, Yuan Q, Hu H, Wang S, Hu MM, Cai C, Wu GS, Jiang C, Zhang YL, Zhang CS, Zhang J
The EMBO journal 2023 Oct 16;42(20):e113743

---

USP51 facilitates colorectal cancer stemness and chemoresistance by forming a positive feed-forward loop with HIF1A.

Mu M, Zhang Q, Li J, Zhao C, Li X, Chen Z, Sun X, Yu J
Cell death and differentiation 2023 Nov;30(11):2393-2407

---

A positive feedback loop between miR-574-3p and HIF-1α in promoting angiogenesis under hypoxia.

Zhang R, Miao Z, Liu Y, Zhang X, Yang Q
Microvascular research 2023 Nov;150:104589

---

Fatty Acid Oxidation Mediated by Malonyl-CoA Decarboxylase Represses Renal Cell Carcinoma Progression.

Zhou L, Luo Y, Liu Y, Zeng Y, Tong J, Li M, Hou Y, Du K, Qi Y, Pan W, Liu Y, Wang R, Tian F, Gu C, Chen K
Cancer research 2023 Dec 1;83(23):3920-3939

---

Hypoxia-Induced LncRNA-MIR210HG Promotes Cancer Progression By Inhibiting HIF-1α Degradation in Ovarian Cancer.

Liu P, Huang H, Qi X, Bian C, Cheng M, Liu L, Xue L, Zhao X, Yi T, Quan Y
Frontiers in oncology 2021;11:701488

---

Septin4 promotes cardiomyocytes apoptosis by enhancing the VHL-mediated degradation of HIF-1α.

Wu S, Zhang Y, You S, Lu S, Zhang N, Sun Y
Cell death discovery 2021 Jul 6;7(1):172